Healthcare Providers Showcase Value of Glytec’s Insulin Management Software During Diabetes Technology Society’s Virtual Hospital Poster Session
Summary
WALTHAM, Mass.--(BUSINESS WIRE)--Glytec, the only provider of insulin management software across the continuum of care, announced today that healthcare providers from five separate health systems will present studies on the transformative effects of implementing its eGlycemic Management System (eGMS) during the 2020 Diabetes Technology Society (DTS) Virtual Hospital Poster Session. Attendees of this online session taking place June 18 at 3 p.m. EDT will hear findings from clinical research into the use of computer-guided insulin dosing and its impact on glycemic management in acute care settings. Results of these studies include reduced hyperglycemic and hypoglycemic events, a decreased financial burden on patients and health systems, and well-documented efficacy of large-scale eGMS utilization. Its FDA-cleared titration software and proprietary algorithms power the only solution capable of delivering personalized diabetes treatment recommendations across the continuum of care, from hospital to home. With ongoing support from its team of doctors, nurses and technologists headquartered outside of Boston, Glytec improves outcomes and controls costs for the large population of patients requiring insulin treatment – including those with and without a diagnosis of diabetes.